These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 6142815)
21. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)]. Lemmer B Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492 [TBL] [Abstract][Full Text] [Related]
22. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol]. Stoschitzky K; Lindner W Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978 [TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Frishman W; Silverman R; Strom J; Elkayam U; Sonnenblick E Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744 [No Abstract] [Full Text] [Related]
25. Rebound phenomena following withdrawal of long-term beta-adrenoceptor blockade. Hjemdahl P; Olsson G Acta Med Scand Suppl; 1982; 665():43-7. PubMed ID: 6130674 [No Abstract] [Full Text] [Related]
26. [Frequent errors in the therapy of heart disease]. Heinecker R Wien Med Wochenschr; 1982 Nov; 132(22):531-6. PubMed ID: 6132496 [No Abstract] [Full Text] [Related]
27. Responses to cardiovascular drugs during alcohol withdrawal. Kähkönen S Alcohol Alcohol; 2006; 41(1):11-3. PubMed ID: 16260447 [TBL] [Abstract][Full Text] [Related]
28. Beta blockers: cardiac jacks of all trades. Uses for beta blockers range from lowering blood pressure to improving heart failure. Harv Heart Lett; 2011 Dec; 22(4):4-5. PubMed ID: 22319827 [No Abstract] [Full Text] [Related]
29. Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites? Krag A; Bendtsen F; Møller S Hepatology; 2011 Jan; 53(1):370-1. PubMed ID: 20815016 [No Abstract] [Full Text] [Related]
30. [Arrhythmic syndrome and sudden death in hypertrophic cardiomyopathy]. Storozhakov GI; Selivanov AI; Kisliak OA Ter Arkh; 1988; 60(8):137-41. PubMed ID: 2906486 [No Abstract] [Full Text] [Related]
31. Letter: Beta-blockade in the presence of renal disease and hypertension. Thompson FD; Joekes AM Br Med J; 1974 Jun; 2(5918):555-6. PubMed ID: 4152140 [No Abstract] [Full Text] [Related]
32. [Letter: Peripheral blood circulation disorders due to beta receptor blockers?]. Sturm A Dtsch Med Wochenschr; 1974 Jun; 99(26):1426. PubMed ID: 4152032 [No Abstract] [Full Text] [Related]
33. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension. Hypertens Res; 1997 Jun; 20(2):61-73. PubMed ID: 9220269 [No Abstract] [Full Text] [Related]
34. [15 years of therapy with beta-receptor blockers. Tendency for differentiation]. Kersting F; Kasper W; Meinertz T Med Klin; 1979 Aug; 74(32-33):1179-88. PubMed ID: 38385 [No Abstract] [Full Text] [Related]
35. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects]. Delius W Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156 [No Abstract] [Full Text] [Related]
37. Role of the autonomic nervous system in sudden death. Verrier RL; Hagestad EL Cardiovasc Clin; 1985; 15(3):41-63. PubMed ID: 2870806 [No Abstract] [Full Text] [Related]
38. The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs. Prichard BN; Walden RJ Br J Clin Pharmacol; 1982; 13(Suppl 2):337S-343S. PubMed ID: 6125186 [No Abstract] [Full Text] [Related]
39. Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances? Hartwell BL; Mark JB Anesth Analg; 1986 Aug; 65(8):905-7. PubMed ID: 2873761 [No Abstract] [Full Text] [Related]